Earnings were rather good. Lots of cash to get us thru the year. I think this company has a lot going for it, and all their work should end up creating a lot of value. IMO, slow cash burning, operations are great and going as planned, meeting all goals... I guess the next thing now is ASCO. Maybe Merck will give us some good news before then. Any which way, we should continue up and I think the market will too.